Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023-Reference-Cited by-同舟云学术

Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023

Published:2024-06-18 Issue:23 Volume:331 Page:2041
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Lee Joyce M.¹,Sharifi Mona²,Oshman Lauren³,Griauzde Dina H.⁴,Chua Kao-Ping¹

Affiliation:

1. Susan B. Meister Child Health Evaluation and Research Center, University of Michigan Medical School, Ann Arbor

2. Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut

3. Department of Family Medicine, University of Michigan Medical School, Ann Arbor

4. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor

Abstract

This study uses data from US retail pharmacies to assess national GLP-1RA dispensing to adolescents and young adults from 2020-2023.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2819128/jama_lee_2024_ld_240025_1717690943.98848.pdf

Reference6 articles.

1. Patents and regulatory exclusivities on GLP-1 receptor agonists.;Alhiary;JAMA,2023

2. Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: a call to action.;Cooper;J Clin Transl Sci,2023

3. Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence.;Muller;Front Endocrinol (Lausanne),2023

4. Eli Lilly. FDA approves Lilly’s Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes. Published May 13, 2022. Accessed November 15, 2023. https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-mounjarotm-tirzepatide-injection-first-and

5. Novo Nordisk. FDA approves once-weekly Wegovy injection for the treatment of obesity in teens aged 12 years and older. Published December 23, 2022. Accessed November 29, 2023. https://www.novonordisk-us.com/media/news-archive/news-details.html?id=151389

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1 Receptor Agonists and Suicidality—Caution Is Needed;JAMA Network Open;2024-08-20

2. Medical Nutrition Therapy: Still Relevant in the Era of Pharmacotherapy for Obesity Care;Journal of the Academy of Nutrition and Dietetics;2024-06